On estimation of vaccine efficacy using validation samples with selection bias

Daniel O. Scharfstein, M. Elizabeth Halloran, Haitao Chu, Michael J. Daniels

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Using validation sets for outcomes can greatly improve the estimation of vaccine efficacy (VE) in the field (Halloran and Longini, 2001; Halloran and others, 2003). Most statistical methods for using validation sets rely on the assumption that outcomes on those with no cultures are missing at random (MAR). However, often the validation sets will not be chosen at random. For example, confirmational cultures are often done on people with influenza-like illness as part of routine influenza surveillance. VE estimates based on such non-MAR validation sets could be biased. Here we propose frequentist and Bayesian approaches for estimating VE in the presence of validation bias. Our work builds on the ideas of Rotnitzky and others (1998, 2001), Scharfstein and others (1999, 2003), and Robins and others (2000). Our methods require expert opinion about the nature of the validation selection bias. In a re-analysis of an influenza vaccine study, we found, using the beliefs of a flu expert, that within any plausible range of selection bias the VE estimate based on the validation sets is much higher than the point estimate using just the non-specific case definition. Our approach is generally applicable to studies with missing binary outcomes with categorical covariates.

Original languageEnglish (US)
Pages (from-to)615-629
Number of pages15
Issue number4
StatePublished - Oct 2006


  • Bayesian
  • Expert opinion
  • Identifiability
  • Influenza
  • Missing data
  • Selection model
  • Vaccine efficacy


Dive into the research topics of 'On estimation of vaccine efficacy using validation samples with selection bias'. Together they form a unique fingerprint.

Cite this